Get complete access to comprehensive company data for Aurobindo Pharma Ltd.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Aurobindo Pharma Ltd
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 666.40 cr
₹ 58.59 cr
26 Dec 1986
31 Mar 2023
Aurobindo Pharma Ltd is an Indian public limited company incorporated on 26 Dec 1986. The company's registered office is situated in Hyderabad, Telangana, India.
The current status of Aurobindo Pharma Ltd is Active. The company has filed its annual returns and financial statements up to 31 Mar 2023 (FY 2022-2023).
Aurobindo Pharma Ltd is a company limited by shares with an authorized capital of ₹666.40 cr and a paid-up capital of ₹58.59 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Aurobindo Pharma Ltd has 10 directors and 2 signatories. The Key Managerial Personnel (KMP) at Aurobindo Pharma Ltd include Santhanam Subramanian as CFO and Adi Reddy Baddigam as Company Secretary. The directors of the company include Deepali Pant Joshi, Savita Mahajan, Mangalam Ramasubramanian Kumar, Santanu Mukherjee.
The registered office of Aurobindo Pharma Ltd is located at Plot No.2,Maithrivihar,Behind Maithri Vanam Ameerpet, Hyderabad Andhra Pradesh Telangana 500038 India in Hyderabad, Telangana, India.
- CIN/LLPIN/FCRN: L24239TG1986PLC015190
- Legal Name: Aurobindo Pharma Ltd
- ROC Code: Roc Hyderabad
- Company No.: 015190
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Public
- Listing Status: Listed
- Industry: Pharma
- Date of AGM: 25 Aug 2023
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Aurobindo Pharma Ltd |
|---|
Frequently Asked Questions
- adi reddy baddigam
- deepali pant joshi
- girish paman vanvari
- madan mohan reddy mettu
- mangalam ramasubramanian kumar
- nityananda reddy kambam
- santanu mukherjee
- santhanam subramanian
- sarath chandra reddy penaka
- satakarni makkapati
- savita mahajan
- venkata ramprasad reddy penaka